We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA officials said they welcomed the Institute of Medicine (IOM) report “The Future of Drug Safety: Promoting and Protecting the Health of the Public,” but reserved reacting to most of the recommendations until they have had time to review the report.